Company / Operating Cash Flow per Share
Bioventus Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.19
FY2025
5-year range
-$0.30 / $1.19
FY2021-FY2025
Trend
+88.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.30 in FY2022 to $1.19 in FY2025.
Based on SEC 10-K filings.
1.19 in FY2025.
Improved from $0.51 to $1.19 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 88.6% year-over-year.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.19 | +88.6% |
| FY2024 | $0.63 | +25.0% |
| FY2023 | $0.51 | +269.8% |
| FY2022 | -$0.30 | -133.2% |
| FY2021 | $0.90 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026